Rankings
▼
Calendar
VCEL FY 2017 Earnings — Vericel Corporation Revenue & Financial Results | Market Cap Arena
VCEL
Vericel Corporation
$2B
FY 2017 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$64M
+17.5% YoY
Gross Profit
$34M
52.5% margin
Operating Income
-$15M
-23.4% margin
Net Income
-$17M
-27.0% margin
EPS (Diluted)
$-0.52
Cash Flow
Operating Cash Flow
-$13M
Free Cash Flow
-$15M
Stock-Based Comp.
$3M
Balance Sheet
Total Assets
$55M
Total Liabilities
$32M
Stockholders' Equity
$23M
Cash & Equivalents
$27M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$64M
$54M
+17.5%
Gross Profit
$34M
$26M
+28.7%
Operating Income
-$15M
-$19M
+22.1%
Net Income
-$17M
-$20M
+11.7%
← Q4 2016
All Quarters
Q1 2017 →